Sökresultat

A team of international researchers led by Professor Johan Jakobsson at Lund University has secured a 52 million SEK grant from the Aligning Science Across Parkinson’s (ASAP) initiative, in partnership with the Michael J Fox Foundation to investigate how mobile genetic elements —commonly referred to as "jumping genes"—contribute to neuroinflammation and the progression of Parkinson’s disease. Jump

https://www.multipark.lu.se/article/52-million-sek-goes-uncovering-genetic-drivers-parkinsons-disease - 2026-05-09

Dear colleagues and collaborators,As we approach the end of 2024, I believe that we can look back with pride on the many things that we have achieved together this year. We would like to thank all of you for your vital contributions to our research environment, encompassing diverse roles and capacities. Next year is poised to be a particularly eventful year for MultiPark. On December 12, the Swedi

https://www.multipark.lu.se/article/seasons-greetings-multipark - 2026-05-09

Dear colleagues and collaborators,Welcome to a new year with MultiPark!Our Management group has now resumed its activities at full pace, and we are happy to share some fresh information as follows:(i) The dates for this year´s meetings of the MultiPark Board and Steering group have been set and posted under this link https://www.multipark.lu.se/about-multipark/management. We welcome Oxana Klementi

https://www.multipark.lu.se/article/kicking-year-packed-program-ahead - 2026-05-09

Don't miss the latest episode of MultiPark's podcast Meet our scientists. MultiPark's newest research group leader, Henrik Ahlenius, shares his expertise about stem cells in aging and neurodegenerative diseases. In this episode, Henrik explains the fascinating interplay between aging, neurodegenerative diseases and stem cells - critical areas of study that Henrik Ahlenius has passionately pursued

https://www.multipark.lu.se/article/meet-our-scientists-podcast-henrik-ahlenius-about-stem-cells-aging-and-neurodegeneration - 2026-05-09

This week marked the kickoff of MultiPark's Advanced Neuroscience Course. In this exclusive program, students from around the world unite to explore neuroscience and the complexities of neurodegenerative diseases. During the Advanced Neuroscience Course, students gain insights from leading researchers and get hands-on lab experience, working closely with labs that match their interests. The course

https://www.multipark.lu.se/article/advanced-neuroscience-course-future-neuroscientists - 2026-05-09

A study at Lund University reveals that traumatic brain injury alters the small vessels in the brain, resulting in an accumulation of amyloid beta — a hallmark of Alzheimer’s disease. The findings suggest that vascular dysfunction could be an early driver in neurodegenerative disorders rather than being caused by neuronal damage. The study is published in Acta Neuropathologica. An increased risk o

https://www.multipark.lu.se/article/cracking-alzheimers-code-how-brain-trauma-triggers-disease - 2026-05-09

This year, MultiPark has the pleasure of welcoming two new research groups. The Mackenzie Lab aims to decode the neurobiological underpinnings of emotion through experimental studies in animal models. Jacob Vogel’s team uses AI to analyze clinical data for improved understanding as well as patient-tailored diagnosis and care of neurodegenerative disease patients. Say hello to Åsa Mackenzie and Jac

https://www.multipark.lu.se/article/multipark-grows-new-research-groups - 2026-05-09

What role does an inflammatory protein have in disease development? Which neuronal circuits cause different symptoms? How may diabetes affect Parkinson’s disease? Can motor signs be identifies early in individuals at risk for the disease? And how should patients in very advanced disease stages be treated to maintain their quality of life? These questions may soon have answers thanks to several ong

https://www.multipark.lu.se/article/molecule-patient-six-promising-projects-advance-parkinsons-research - 2026-05-09

Researchers at Lund University and Washington University have identified a blood marker that reflects the amount of Alzheimer’s pathology in the brain. This discovery may play a key role in determining who is most likely to benefit from the new Alzheimer’s drugs. In brief:A newly discovered blood marker, MTBR-tau243, can reveal how much Alzheimer’s disease pathology is present in the brain. The hi

https://www.multipark.lu.se/article/new-reliable-blood-marker-reveals-extent-alzheimers-pathology-brain - 2026-05-09

A simpler method of analysing blood samples for Alzheimer’s disease has been tested in a large multicentre study, led by Lund University in Sweden. “This is a major step in bringing simple blood tests for Alzheimer’s disease into the healthcare system globally,” say the researchers behind the study. In brief:The blood-based marker (P-tau217) may start to change several years before the onset of Al

https://www.multipark.lu.se/article/more-opportunities-test-alzheimers-using-new-analytical-method - 2026-05-09

Knut and Alice Wallenberg Foundation has in cooperation with Åsa Petersén produced a short film about Huntington's disease and Petersén's research on HD. Petersén was awarded Wallenberg Clinical Scholar in 2020. Link to the movie "Huntington's disease - the hunt for treatment" on YouTube  

https://www.huntington-research.lu.se/article/film-about-hd-asa-petersen - 2026-05-09

Curious about HD research and wish to learn more? The European Huntington Association/Moving Forward Team is inviting you to a webinar in Norwegian on 22 November. Astri Arnesen, the President of the European Huntington Association, will speak about international HD research, Lasse Pihlstrøm, a Norwegian HD neurologist and researcher, will address HD studies and trials in Norway, and Åsa Petersén,

https://www.huntington-research.lu.se/article/hd-webinar-22-november-2023 - 2026-05-09

The European Huntington Association/Moving Forward Team’s webinar in now available on our site! You find it under Talks & Movies:Talks & Movies

https://www.huntington-research.lu.se/article/watch-webinar - 2026-05-09

The National meeting for HD is a yearly event arranged by the patients’ organization RHS. This year, 2023, it took place in Gothenburg on 30 November. All talks at the meeting are available on RHS website; only in Swedish.You find Åsa Petersén’s research update about 13 minutes into the film. To access the video, go to RHS website:RHS website

https://www.huntington-research.lu.se/article/petersen-gives-research-update-national-meeting-hd-sweden - 2026-05-09

Every spring, Huntington Disease Center in Lund traditionally hosts an information night on Huntington disease. This year is no exception! The program is set for the evening:Staff from the clinical team and representatives from the patients’ organization, RHS, as well as HD researchers, will give talks about different aspects of the the disease and the current research. And, as always, there will

https://www.huntington-research.lu.se/article/welcome-info-night-hd-22-april-2024 - 2026-05-09

Sofia Bergh, PhD student in TNU, gave two presentations on Huntington disease on 11 and 12 March 2024 during the NMT Days.This is an annual event, arranged by the Faculty of Science, the Faculty of Medicine and the Faculty of Engineering at Lund University. A week of talks and demonstrations on a variety of topics show today’s research, and students in upper secondary school and their teachers are

https://www.huntington-research.lu.se/article/bergh-presented-nmt-days - 2026-05-09

Åsa Petersén gave a talk about Huntington disease and her research for the patients' organization, RHS, in Stockholm on 12 March 2024, where she was invited.

https://www.huntington-research.lu.se/article/petersen-gave-hd-talk-stockholm - 2026-05-09

Sofia Bergh's talk from the NMT days is now available online. See more on the Talks & Movies page.

https://www.huntington-research.lu.se/article/see-sofia-berghs-talk-hd - 2026-05-09

Sofia passed her half time review on 28 May 2024. Sofia Bergh presented her work titled "Cellular and molecular mechanisms of hypothalamic pathology in Huntington disease and the amyotrophic lateral sclerosis/frontotemporal dementia disease spectrum" before the audience and the reviewers Niels Henning Skotte, research group leader, Department for Drug Design and Pharmacology, Molecular Neuroprotec

https://www.huntington-research.lu.se/article/congratulations-sofia-bergh - 2026-05-09

For the second time, the European Huntington Association/Moving Forward initiative for the Nordic countries will be hosting a webinar on research updates. The Webinar will be held on 11th June, from 18:00 CET to 19:15 CET. You need to register beforehand to be able to join.Registration link: https://us02web.zoom.us/meeting/register/tZEkdeyupz4oH9KRCnkguo_KMuS0Y6…Åsa Petersén will be talking about

https://www.huntington-research.lu.se/article/webinar-research-updates-nordic-countries - 2026-05-09